Search

Improved survival for adult Acute Lymphoblastic Leukemia (ALL) patients

Jun 11 2016 Posted in Press releases

Historical survival for patients 18-45 years with ALL is approximately 40 %. However the event free survival for ALL patients 18-45 years has improved to 73% following implementation of the NOPHO ALL2008 protocol in July 2008.

Harnessing new developments in genomics to improve outcome for children with poor prognosis leukemia

Apr 30 2014 Posted in Press releases

At the 19th Congress of the European Hematology Association (EHA), we will learn about the state-of-the-art in management of childhood AML.

European Board for Accreditation in Hematology

Current committee members
Harry Schouten, The Netherlands (Chair)
Anna Porwit, Sweden (Vice-Chair)
Gunnar Birgegård, Sweden, General skills and ethics
Peter van den Burg, The Netherlands, Transfusion Medicine (ISBT)
Eleni Gavriilaki, Greece (Representative clinical hematology)
Michelle Kenyon, United Kingdom, Specialized Hematology Professional (EBMT Nurses Group)
Fionnuala Ní Áinle,…

SPC Advisory Board, EHA Congress 2024

Current committee members
Valentine Brousse, France
Veronika Buxhofer-Ausch, Austria
Ana Cvejic, Denmark
Mattia D'Agostino, Italy
Thierry Facon, France
Krystof Giannopoulos, Poland
Julia Hauer, Germany
Dan Hodson, United Kingdom
Sören Lehmann, Sweden
Georg Lenz, Germany
Sirpa Leppä, Finland
Karina Meijer, The Netherlands
Emma Morris, United Kingdom
Cristina Papayannidis, Italy
France Pirenne, France
Delphine Rea, France
Sonata Šaulytė Trakymienė, Lithuania
Barbara…

Advances from genome sequencing are paving the way to personalized treatment for leukemia and pre-leukemia

Apr 04 2014 Posted in Press releases

In acute myeloid leukemia (AML) our understanding of how modifications to DNA molecules that do not result in sequence change (i. e.